Why is the Meningococcal C Conjugate vaccine important?
Serogroup C has been almost exclusively responsible for localized clusters or outbreaks of invasive meningococcal disease in schools and communities. In Ontario, many of the cases are in adolescents and young adults. This is why the vaccine is now publicly funded for children aged 12 years (generally in grade 7) and youth aged 15 to 19 years. How well do Meningococcal C Conjugate vaccines protect against disease? The vaccine is up to 90% effective in those who receive the recommended dose. How often do I need to get this vaccination? At this time it has been shown that only one dose of the vaccine is needed to provide coverage against invasive meningococcal disease serogroup C. Is Meningococcal C Conjugate vaccine safe? Yes. Menjugate was introduced into the routine infant immunization schedule in the United Kingdom in 1999 with no serious side effects reported. Side effects are usually mild and last only for a few days. Side effects, listed in order of frequency, may include: • Mild p
Related Questions
- What are the guidelines for revaccination with meningococcal conjugate vaccine (MCV) if a child has previously received meningococcal polysaccharide vaccine (MPSV)?
- Does Menactra Meningococcal Conjugate Vaccine cause Guillain-Barré Syndrome (GBS)?
- How much does Menactra (Meningococcal Conjugate Vaccine) cost?
